• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Tagged: study

  • Blind For Blindness: Preventing Childhood Blindness
    • in Public Health
    • — 28 May, 2008

    Blind For Blindness: Preventing Childhood Blindness

    Hessom Razavi,  Puneet Sayal, Claire Gilbert
    Hessom Razavi, Puneet Sayal, Claire Gilbert

    Hessom Razavi, Puneet Sayal, Claire Gilbert, London School of Hygiene and Tropical Medicine
    Eye doctor Hessom Razavi volunteered to go about his usual studies at the London School blindfold for 24 hours to
    …
    Read more
    Bivalirudin For Angioplasty: Expensive Heparin?
    • in Cardiovascular
    • — 30 Apr, 2008

    Bivalirudin For Angioplasty: Expensive Heparin?

    Tony Gershlick
    Tony Gershlick

    Tony Gershlick, University of Leicester
    Adnan Kastrati, Deutsches Herzzentrum, Munich
    Using bivalirudin instead of heparin during angioplasty wasn’t any better for preventing death, MI or urgent revascularisation in the 4,500-patient ISAR-REACT 3 study presented at the
    …
    Read more
  • Never Too Old For Hypertension Treatment!
    • in Cardiovascular
    • — 8 Apr, 2008

    Never Too Old For Hypertension Treatment!

    Nigel Beckett
    Nigel Beckett
    Nick Boon
    Nick Boon

    Nigel Beckett, Imperial College, London
    COMMENT: Nick Boon, British Cardiovascular Society, London

    Even very old patients benefit greatly if you treat their hypertension. This is the finding of the randomized HYVET study of 4,000 patients with
    …
    Read more
    Bevacizumab: New Standard for Non-Small Cell Lung Cancer?
    • in Oncology
    • — 16 Mar, 2008

    Bevacizumab: New Standard for Non-Small Cell Lung Cancer?

    Christian Manegold
    Christian Manegold
    Nick Thatcher
    Nick Thatcher
    Christian Manegold, Heidelberg University Medical Center, Manheim
    Nick Thatcher, Christie Hospital, Manchester

    Is bevacizumab a new standard of care for patients with unresectable non-small cell lung cancer who have good performance status? This question

    …
    Read more
  • Cetuximab Extends Survival In Advanced Non-Small Cell Lung Cancer
    • in News
    • — 16 Mar, 2008

    Cetuximab Extends Survival In Advanced Non-Small Cell Lung Cancer

    Robert Pirker
    Robert Pirker

    ROBERT PIRKER , Medical University of Vienna
    Phase III study results have detected improvements in overall survival among patients with advanced non-small cell lung cancer treated with a monoclonal antibody targeted to the epidermal growth factor receptor: EGFR.
    …
    Read more
    Lung Cancer Screening: Wait for Prospective Study Findings!
    • in News
    • — 16 Mar, 2008

    Lung Cancer Screening: Wait for Prospective Study Findings!

    Ugo Pastorino
    Ugo Pastorino

    UGO PASTORINO , Istituto Nazionale Tumori, Milan
    Even the most sophisticated and powerful detection method for lung cancer detection, spiral CT, is still unproven in the context of mass screening for lung cancer. At the conference in Turin,
    …
    Read more
  • London School of Hygiene & Tropical Medicine Audio News – Undernutrirtion Causes a Third of Child Deaths
    • in Public Health
    • — 17 Jan, 2008

    London School of Hygiene & Tropical Medicine Audio News – Undernutrirtion Causes a Third of Child Deaths

    Zulfiqar Bhutta
    Zulfiqar Bhutta

    Reference: The Lancet, Maternal and Child Undernutrition Special Series
    With one child in three killed by it, childhood and maternal undernutrition are discussed in a special series of articles in the Lancet. Sarah Maxwell spoke with Zulfiqar Bhutta
    …
    Read more
    Non Drug Intervention: Better Than Antipsychotic Drugs for Aggressive Challenging Behaviour in Intellectual Disability
    • in General Medicine
    • — 4 Jan, 2008

    Non Drug Intervention: Better Than Antipsychotic Drugs for Aggressive Challenging Behaviour in Intellectual Disability

    Peter Tyrer
    Peter Tyrer

    REFERENCE: Lancet 371:57 January 5, 2008
    PETER TYRER, Imperial College, W6 8RP London
    A randomized study comparing treatment with risperidone, or haloperidol, or placebo to treat patients who have intellectual disability presenting with a syndrome commonly labelled as
    …
    Read more
    • in Oncology
    • — 11 Dec, 2007

    Live Report from ASH:
    Ibritumomab Provides Benefit in Patients with Follicular Lymphoma

    Anton Hagenbeek
    Anton Hagenbeek

    ANTON HAGENBEEK, University Medical Centre Utrecht
    For patients with advanced-stage follicular non-Hodgkin’s lymphoma, ibritumomab tiuxetan seems to prolong progression free survival by two years with favourable toxicity. Sarah Maxwell spoke to study author Anton Hagenbeek at the ASH
    …
    Read more
    • in Oncology
    • — 11 Dec, 2007

    Live Report from ASH:
    Can Intensive Immunochemotherapy Cure Mantle Cell Lymphoma?

    Christian Geisler
    Christian Geisler

    CHRISTIAN GEISLER, Rigshospitalet, Copenhagen
    Mantle cell lymphoma, which was previously considered incurable, has apparently been cured in some patients on a phase II study. Derek Thorne got the details on the study – which featured an intensive immunochemotherapy
    …
    Read more
  • Live Report from ASH: Azacitidine ‘New Standard’ In High Risk Myelodysplastic Syndromes
    • in Oncology
    • — 10 Dec, 2007

    Live Report from ASH: Azacitidine ‘New Standard’ In High Risk Myelodysplastic Syndromes

    Pierre Fenaux
    Pierre Fenaux

    PIERRE FENAUX, Paris 13 University
    Results from a phase III study presented at ASH suggest that the hypomethylating agent azacitidine should be the new standard of care for patients with high-risk MDS. Pierre Fenaux of Paris 13 University
    …
    Read more
    New Drug AMG 531 Effective in Splenectomized Patients with Chronic Immune Thrombocytopenic Purpura
    • in General Medicine
    • — 9 Dec, 2007

    New Drug AMG 531 Effective in Splenectomized Patients with Chronic Immune Thrombocytopenic Purpura

    Terry Gernsheimer
    Terry Gernsheimer

    TERRY GERNSHEIMER, University of Washington Medical Center, Seattle
    An investigational drug AMG 531 has increased and sustained platelet counts in splenectomized patients with chronic immune thrombocytopenic purpura or ITP. This was in a placebo controlled phase III trial
    …
    Read more
  • Next Page »
  • Sign up for AudioMedica.com news

    * = required field
    Speciality




  • Home
  • Tagged: study

© Copyright 2022 AudioMedica.com. Typegrid Theme by WPBandit.